48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This is a 48-week study to collect information on the safety and activity of an
investigational medicine in patients, ages 2 to 18 years old, with HIV infection .